Clinical Trial Update: Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating a controlled-release formulation of varenicline in adult smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Varenicline (controlled release formulation) (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED